What Cris Pharma does

Cris Pharma (India) Limited is a privately held pharmaceutical contract manufacturer founded in 1992 and headquartered in Jaipur, India. The company operates a WHO-GMP certified and ISO 9001:2015 compliant manufacturing facility located in a Special Economic Zone at Selaqui, Dehradun, Uttarakhand, which has been operational since June 2006. Production is concentrated on two dosage formats: tablets (including direct compression, aqueous-coated, enteric-coated, modified/sustained release, dispersible, and bi-layer variants) and liquid orals (oral suspensions and syrups). The in-house quality control laboratory is equipped with HPLC, FTIR, dissolution apparatus, and UV spectrophotometer across physico-chemical, instrumental, microbiological, and packaging material testing sections. The company's product portfolio comprises generic formulations such as Aceclofenac + Paracetamol tablets, Acetaminophen combinations, Albendazole suspension, and Ambroxol + Salbutamol syrup.

The business model is exclusively B2B contract manufacturing (CMO), with no direct-to-consumer sales. Cris Pharma manufactures on behalf of "leading Indian pharmaceutical MNCs" for both domestic distribution and international export, with pricing handled on a quote basis tied to product specifications, volume, and regulatory requirements. Revenue is generated from contract manufacturing fees and export sales to seven countries spanning West Africa (Nigeria, Ivory Coast, Ghana), East Africa (Kenya, Uganda), Southeast Asia (Myanmar), and Central Asia (Uzbekistan). International regulatory affairs capabilities include CTD/ACTD dossier preparation and submission per the requirements of each country's Ministry of Health. Distribution is entirely direct-to-pharma-company (B2B), with no third-party logistics, retail, or e-commerce channels.

The company is managed by four directors (two at the Jaipur corporate office, one technical and one executive director at the Dehradun manufacturing facility) plus dedicated heads of Quality Control and Quality Assurance. It is part of a broader pharmaceutical group that includes Oasis Test House Limited (a leading Indian analytical services provider based in Ahmedabad and Jaipur) and Oasis Infotech (developer of OasisLIMS pharma ERP software), giving the group four decades of pharmaceutical sector experience. The company is privately held with no disclosed external investors, funding rounds, or parent company affiliation, and appears to be founder/management-owned.

Name

Cris Pharma

Legal name

Cris Pharma (India) Limited

Website

https://crispharma.com

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

101–250 employees

Short description

Cris Pharma (India) Limited is a private pharmaceutical contract manufacturer operating a WHO-GMP certified facility in Dehradun that produces generic tablets and liquid orals for leading Indian pharmaceutical MNCs and export markets across Africa and Asia.

Ownership category

akta.pro rank

Headquarters

HQ city

Jaipur

HQ country

India

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Contract Manufacturing Services: Cris Pharma generates revenue through contract manufacturing pharmaceutical formulations (Tablets and Liquid Orals) for domestic and export markets. The company manufactures products on contract basis for leading pharmaceutical companies, providing full-service manufacturing from process development to commercial scale production.
2. Export of Manufactured Drugs: Revenue from exporting manufactured pharmaceutical products to international markets including Nigeria, Myanmar, Ghana, Kenya, and Uganda. The company has regulatory approvals in multiple Francophone and African countries.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Cris Pharma is a pharmaceutical contract manufacturer that produces Tablets and Liquid Orals on a P2P basis for leading Indian pharmaceutical companies and international buyers. The company operates a WHO-GMP certified manufacturing facility at SEZ, Dehradun, offering full-service production from formulation R&D and stability/validation studies to commercial-scale manufacture, and supports regulatory submissions (CTD/ACTD dossiers) for export markets.

Product overview

Cris Pharma is a pharmaceutical manufacturing company offering a portfolio of generic pharmaceutical formulations consisting of Tablets and Oral Liquids. The tablet product line includes analgesic and anti-inflammatory medications such as Aceclofenac and Paracetamol combinations, while the oral liquid portfolio includes pediatric suspensions, anthelmintic solutions, and respiratory syrups. Beyond product manufacturing, the company provides contract manufacturing services encompassing formulation research and development, stability studies, and validation studies. The company operates a WHO-GMP certified manufacturing facility for both domestic and international markets.

Differentiator

Problem solved

Functional benefit

Products and services

• Contract Manufacturing Services Pharmaceutical contract manufacturing services covering formulation research and development, periodic and accelerated stability studies, validation studies, new method development, and commercial-scale production of Tablets and Liquid Orals for domestic and export markets.
• Aceclofenac and Paracetamol Tablets Film coated tablets containing Aceclofenac BP 100 mg and Paracetamol BP 325 mg, used as analgesic and anti-inflammatory medication.
• Aceclofenac & Acetaminophen Tablets Uncoated tablets containing Acetaminophen USP 325 mg, used for pain relief and fever reduction.
• Acetaminophen with Caffeine Tablets USP Uncoated tablets containing Acetaminophen USP 500 mg and Caffeine USP 65 mg, combining analgesic with stimulant properties.
• Acetaminophen with Phenylephrine Tablets Uncoated tablets containing Phenylephrine Hydrochloride USP 5 mg, used for cold and sinus relief.
• Acetaminophen Oral Suspension USP (125mg) Oral suspension containing Acetaminophen USP 125 mg per 5 ml, pediatric formulation for fever and pain relief.
• Acetaminophen Oral Suspension USP (250mg) Oral suspension containing Acetaminophen USP 250 mg per 5 ml, for fever and pain management.
• Albendazole Suspension Oral suspension containing Albendazole USP 200 mg per 5 ml, used for parasitic worm infections.
• Ambroxol Hydrochloride & Salbutamol Syrup Syrup containing Ambroxol Hydrochloride BP 15mg and Salbutamol Sulphate BP 1mg per 5 ml, used as expectorant and bronchodilator.

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Oasis Test House LimitedcoreOthersGroup company providing commercial testing laboratories and leading analytical services in India. Located at Ahmedabad and Jaipur, it supports quality assurance and testing capabilities for Cris Pharma's pharmaceutical manufacturing operations.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Strides Pharma: Indian generic manufacturer with strong presence in Africa and other emerging markets; comparable as an Indian pharma exporter focused on oral solids and semi-regulated markets, including Africa.
• Aurobindo Pharma: Major Indian generic manufacturer with significant export operations across Africa, Asia, and regulated markets; comparable as an Indian pharma exporter with strong presence in Nigeria and other African geographies served by Cris Pharma.
• Divi's Laboratories: Large Indian API and contract manufacturer exporting globally with strong regulatory track record; comparable as an Indian pharma exporter with WHO-GMP facilities serving international pharma MNCs, though at much greater scale and API-focused.
• Syngene International: Leading Indian CRO/CDMO providing contract research, development, and manufacturing services to global pharma; comparable contract services model serving international pharma clients, broader in scope including biologics and clinical research.
• Recipharm: European-headquartered CDMO offering contract manufacturing of oral solids, sterile, and other dosage forms; comparable as a contract manufacturer serving pharma clients across geographies, though primarily focused on regulated markets.
• Lonza Group: Global CDMO leader providing contract manufacturing across multiple dosage forms to pharma and biotech; comparable as a contract manufacturer serving pharma clients with regulatory-grade facilities, though at significantly larger scale and broader scope.
• Jubilant Pharmova: Indian pharma services company spanning CDMO, generics, and radiopharma; comparable as an Indian contract manufacturer and exporter with international regulatory approvals and global pharma clients.
• Dr. Reddy's Laboratories: Large Indian pharma company with global manufacturing footprint and significant Africa/emerging-market presence; comparable as Indian pharma with WHO-GMP facilities and export operations across geographies where Cris Pharma operates.

Regional players

• Laurus Labs: Indian pharmaceutical company with CDMO services and strong emerging-market focus; comparable as an Indian pharma manufacturer and exporter, though with stronger API and ARV focus and broader product portfolio.

Direct peers

• Piramal Pharma Solutions: Indian-headquartered CDMO offering contract development and manufacturing across multiple dosage forms for global pharma companies; directly comparable as an Indian contract manufacturer serving MNC clients, though at significantly larger scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/crispharma
• LinkedInlinkedin.com/company/cris-pharma-india-limited

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cris Pharma